home / stock / tela / tela news

TELA News and Press, TELA Bio Inc. From 11/09/23

Stock Information
Company Name: TELA Bio Inc.
Stock Symbol: TELA
Market: NYSE
Website: telabio.com
Menu
TELA TELA Quote TELA Short TELA News TELA Articles TELA Message Board
Get TELA Alerts

News, Short Squeeze, Breakout and More Instantly...
TELA - Expected earnings - TELA Bio Inc.

TELA Bio Inc. (TELA) is expected to report $-0.51 for Q3 2023
TELA - TELA Bio to Announce Third Quarter 2023 Financial Results

MALVERN, Pa., Oct. 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the pa...

TELA - TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

MALVERN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patien...

TELA - TELA Bio, Inc. (TELA) Q2 2023 Earnings Call Transcript

2023-08-09 21:00:21 ET TELA Bio, Inc. (TELA) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Louisa Smith – Gilmartin Group Tony Koblish – President and Chief Executive Officer Roberto Cuca – Chief Operating Of...
TELA - TELA Bio GAAP EPS of -$0.46 beats by $0.05, revenue of $14.5M beats by $0.1M

2023-08-09 16:45:50 ET TELA Bio press release ( NASDAQ: TELA ): Q2 GAAP EPS of -$0.46 beats by $0.05 . Revenue of $14.5M (+39.4% Y/Y) beats by $0.1M . For further details see: TELA Bio GAAP EPS of -$0.46 beats by $0.05, revenue of $14.5M beats by $0.1M

TELA - TELA Bio Reports Second Quarter 2023 Financial Results

MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own ana...

TELA - TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the pa...
TELA - TELA Bio: Turning More Constructive

2023-06-21 20:00:00 ET Summary TELA Bio presents with reasonable financials, underlying market growth and business economics. However, the company's current lack of operating profitability is a factor to consider as well. Despite this, TELA should be closely monitored for pote...

TELA - New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MALVERN, Pa., June 15, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc . (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patien...

TELA - TELA Bio to Participate in the Jefferies Global Healthcare Conference

MALVERN, Pa., May 25, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own a...
Previous 10 Next 10